The Europe sales of radiotherapy patient positioning is estimated to be worth USD 135.1 million in 2024 and anticipated to reach a value of USD 196.1 million by 2034. Sales are projected to rise at a CAGR of 3.8% over the forecast period between 2024 and 2034. The revenue generated by Vascular Patches in 2023 was USD 130.1 million. The industry is anticipated to exhibit a Y-o-Y growth of 3.9% in 2024.
In last decade, there has been a significant rise in the number of cancer cases globally and patient positioning plays a key role for patient undergoing radiotherapy. Patient positioning devices are demanded across all radiation therapy centers as a cancer treatment component to mitigate radiation exposure to other tissues.
There is thus a growing need for more advanced patient positioning systems which ensure radiation treatment accuracy and consistency in the radiation doses in the effected areas. One of the primary reason leading to a positive growth remains continuous innovation of sophisticated positioning tools and techniques like 3D images, real-time tracking, and robotic devices. In fact, they enhance treatment outcomes while enhancing patient alignment precision in the process.
Europe Radiotherapy Patient Positioning Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 130.1 million |
| Estimated Size, 2024 | USD 135.1 million |
| Projected Size, 2034 | USD 196.1 million |
| Value-based CAGR (2024 to 2034) | 3.8% |
In Europe, the radiotherapy patient positioning market is being driven strongly by the rising incidence rates of cancer. The more patients require radiotherapy, the more they want technologically-advanced patient positioning systems to guarantee accurate and efficient treatment. They optimize outcomes of radiotherapy as they aim at cancer cells with minimum impacts on near healthy tissues.
The Radiotherapy Patient Positioning Market in Europe seems about to climb because of several emerging opportunities. The quality of treatment has been improved by improvements in imaging as well as positions technologies following real-time tracking which enhances precision during therapy processes while also minimizing chances for radiotherapy side effects through adaptation process; however much more still needs to be done since this matter concerns our very lives whose value can never be overestimated.
In order for it to be able to correct its variable errors depending on how each person is placed in the bed, it should be automated and robotic. In the context of patient placement, the artificial intelligence (AI) is performing a major role by virtue of its accuracy and consistency. When using robots, it is possible because they align patients in an accurate manner which ensures same care is given to the target areas.
Because sophisticated radiation methods require this degree of accuracy, robotic positioning devices are a major market growth driver. According to Cancer Research UK, patients in England are more likely to undergo surgery and chemotherapy in the early stages of cancer. These alternative treatment options are restraining the growth of the radiotherapy patient positioning market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The table below compares the Compound Annual Growth Rate (CAGR) for the Europe radiotherapy patient positioning market between 2023 and 2024 for the first half of each year. This analysis highlights key changes and trends in revenue generation, offering valuable insights into the market's performance. The period from January to June is considered the first half (H1), while July to December constitutes the second half (H2).
| Particular | Value CAGR |
|---|---|
| H1 | 4.7% (2023 to 2033) |
| H2 | 4.4% (2023 to 2033) |
| H1 | 3.8% (2024 to 2034) |
| H2 | 3.5% (2024 to 2034) |
The above table presents the expected CAGR for the Europe radiotherapy patient positioning market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 4.7%, followed by a slightly lower growth rate of 4.4% in the second half (H2) of the same decade.
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to increase slightly to 3.5% in the first half and increase moderately at 4.5% in the second half. In the first half (H1) the market witnessed a decrease of 90 BPS while in the second half (H2), the market witnessed a decrease of 90 BPS.
The Radiotherapy Patient Positioning Market is driving amidst Surging Prevalence of Cancer
The mortality rate associated with different cancer stages also rises as cancer incidence does. As a result, people who develop cancer tend to interact with healthcare providers early enough. This development compels the health care segment to improve on its physical resources and hence enhancing it (market growth) during future years. According to the World Health Organization (WHO) cancer is the second important cause of mortality and morbidity in Europe, next only to cardiovascular diseases, with more than 3.7 million new cases annually and 1.9 million deaths.
According to Future Market Insights, the market is highly fragmented, with a significant presence of companies headquartered in the Scandinavian regions of Europe. The demand for radiation therapy in healthcare is increasing due to rapid technological progress in radiotherapy equipment such as the introduction of 3D imaging, real-time tracking as well as robotic positioning systems.
As a result, medical practitioners have embraced its use as they are continually looking to provide better solutions around it. The integrated technology helps to improve the precision of patient alignment while at once enhancing effectiveness of the treatment methods used in radiotherapy when targeting cancer cells.
3D imaging technology has the Potential for Creating the Opportunities in the Europe Radiotherapy Patient Positioning Industry
Radiation therapy now includes 3D imaging technology, which makes it possible to see tumour locations and surrounding tissues in great detail. Thanks to this improved imaging capacity, patients may be positioned with maximum accuracy, allowing for precise targeting of malignant cells with little exposure to healthy tissues.
This advanced technology enables the more accurate imaging of tumors and tissues around them, thereby helping in better accuracy in the positioning of patients. 3D imaging is done in order to enhance the alignment and targeting during radiotherapy sessions.
The use of 3D imaging during radiotherapy sessions reduces the chances of undesired irradiation of normal tissues and enhances the potency of the delivered cancer treatment. With increasing adoption by healthcare providers, the demand for more effective and personalized solutions in cancer care will help the European radiotherapy patient positioning industry proceed with a growth path.
Contemporary radiotherapy considers 3D imaging as crucial because of its high treatment efficiency and low side effects. The motion of patients is tracked throughout therapy sessions by monitoring gadgets that are able to detect and correct any small displacement immediately. This is why it is necessary to always monitor such treatments as for tumors found in parts of the body that have a lot of movement like the abdomen or lungs.
Regulatory Challenges Make It Difficult for New Companies to Enter Europe's Radiotherapy Patient Positioning Market
One of the biggest hurdles to regulatory compliance is acquiring certifications such as the CE mark that show products meet healthcare, security, or environment standards when sold in the European Union and surrounding environs. Therefore, opting for these marks means going through rigorous documentation processes as well as conducting a number of clinical experiments for a long time that may delay introduction of new items.
The regulatory environment is quite a barrier to entry, making it tough for any new company to compete with established organizations that have met those stringent standards. Overcoming such challenges is quite necessary for new entrants to establish and maintain product success in the European market.
These rules can be costly to adhere to and thus act as a monetary burden on enterprises, particularly the smaller and medium sized ones. In addition to the regulatory filing fees and compliance audits, these costs consist of the alteration of products and procedures so that they adhere to rules.
These financial obligations can be especially deterrent for smaller businesses with tighter funds, which may inhibit market innovation and competitiveness. Furthermore, the development of alternative cancer treatments, such as immunotherapy and breast lesion localization devices, is also limiting market expansion. There is an increasing focus on creating painless, unique positioning methods, which further restricts market growth.
Principal Consultant
The Europe radiotherapy patient positioning industry recorded a CAGR of 3.5% during the historical period between 2019 and 2023. The growth of radiotherapy patient positioning industry was positive as it reached a value of USD 130.1 million in 2023 from USD 108.9 billion in 2019.
There is increasing demand for sophisticated positioning solutions due to an ever-growing adoption rate for hybrid radiotherapy systems that integrate imaging and therapeutic utilities. The European radiotherapy patient positioning market was progressively advancing before the COVID-19 pandemic, fueled by technological advancements, increased cancer prevalence and surge in healthcare investments.
The crisis initially had an impact on connections and services in health, such as radiotherapy on account of the imposed order of staying in the house and concentrating on patients who were affected by COVID-19. It did however highlight the need for robust and improved healthcare systems. After the pandemic there’s a focus on reinforcing the health infrastructure as well as implementing new technologies quickly. The need for minimizing patient visits and optimizing treatment efficiency has driven the adoption of more sophisticated and remote-capable positioning systems.
Tier 1 organizations enjoy a sales turnover of more than USD 100 million per annum and control 54.3% of the European market. They hold top positions due to their big production volumes, numerous product types and distribution networks in the entire Europe. They have specialized in the production and recycling lines of different packaging forms with a large customer population.
There are three major high-ranking companies in this industry - Orfit Industries, Candor ApS and Eckert & Ziegler BEBIG. Their wide spectrum includes reprocessing, reclaiming and fabrication using state-of-the-art technology complying with regulations’ demands so far as this gives an assurance for quality of the highest level.
Tier 2 companies fall under medium-sized businesses that generate revenues ranging from fifty to a hundred million dollars (USD) annually. Tier 2 owns 28.6% market share; has strongholds in defined areas and palpable impacts upon regional markets. Such entities exhibit robust international footprints with profound market understanding; also possessing viable technology platforms that comply with regulations though they may not possess the farthest fetching tech within Europe. Prominent Tier 2 companies include Qfix, Elekta, Candor ApS among others.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the radiotherapy patient positioning market for different countries. Market demand analysis on key countries in Europe. The Germany is projected to witness a CAGR of 1.9% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| France | 3.2% |
| Italy | 2.9% |
| UK | 2.3% |
| Spain | 3.6% |
Germany radiotherapy patient positioning market is poised to exhibit a CAGR of 1.9% between 2024 and 2034. The market growth is anticipated to be fueled by the rising focus on precision medicine as well as increasing elderly population in Europe, as individuals aged 60 and above face a heightened risk of cancer development.
Thus, Germany's leadership in precision medicine is heading the radiotherapy patient positioning market to a higher extent. Precision medicine is the process of individualization of treatment plans based on the unique features of every patient’s genetic conditions, tumor profile, and general health condition. It involves highly accurate techniques of radiotherapy for cancer treatment where the precision of patient positioning forms the keystone.
Accurate positioning means the radiation dose is confined to a known target the tumor and that as little radiation as possible falls on surrounding healthy tissue. It reduces the risk of developing side effects, and the treatment can be as effective as possible to ensure better outcomes for the patient. With progress in precision medicine, demand has risen accordingly for sophisticated positioning systems that can accommodate such highly individualized plans of treatment.
Italy’s market is anticipated to grow at a CAGR of 2.9% throughout the forecast period. Italy is currently leading in the development of advanced radiotherapy technologies that can treat different types of tumors. In overall treatment of cancer, radiation therapy plays a key role; it has significantly helped in the upsurge of survival rates that could go to a margin of 72%, especially with 3D techniques coming into play.
Furthermore, the cancer management has changed significantly because of the improvement in Modulated radiation therapy and Stereotactic radiosurgery and radiotherapy (IMRT) (SRS and SRT); this implies that there are more accurate and efficient ways of treating the disease.
IMRT simply changes the intensity of the beams so that their form is in line with the tumor shape to minimize side effects and enhance patient outcome. In a closely related situation, SRS and SRT are non-invasive versions of surgery, offering an unusually high radiation dose with astonishing accuracy in just a few sessions.
It is anticipated that these improvements would be one of the key factors driving the expansion of Italy's radiotherapy patient positioning market.
France is one of the leading country for investing greatly in medicinal techniques and invention as well as possessing fine healthcare facilities. The requirement for cancer therapies by means of radiations is boosted furthermore by an increased number of investments and funding in radiotherapy sector in that country.
Innovative patient positioning solutions will be required due to growing demand for radiotherapy in France, a country that has been experiencing increasing cancer incidence rates. As people grow older and more of them get affected by cancer, effective radiotherapy treatments will be even more critical.
This means that the funding of the sector makes it easy for the health care providers to be able to invest in ulterior technologies, that is, which include the use of image-guided radiotherapy and adaptive radiotherapy that is done with correct positioning of the patient for the best results in treatments.
Physicians, on the other hand, can better handle patients through prescribing customized radiation doses causing minimal damage on surrounding normal tissues using method such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), thus improving their quality of life.
The section contains information about the leading segments in the industry. By product, the markers segment is taking the market share of 29.3%.
| Product | Markers |
|---|---|
| Value Share (2024) | 29.3% |
As per product category in 2024, the sector for Markers stands out for taking a control of more than 30.0% of the total share. In tumor location, precise radiation delivery and provision of ideal radiation doses within desired sections, markers play key roles.
Markers are notable for their contribution in lessening radiation exposure on healthy tissues which goes a long way in enhancing treatment safety as well as efficacy. They have more developed features that aid in finding tumors more accurately hence ensuring that radiation therapy is accurately administered with little harm to other surrounding cells.
Their use is increasing with the increasing number of health professionals who find their worth in effectual treatment. In addition, IGRT and other advanced radiotherapy techniques needing accurate tumor positioning are also being adopted at a rapid pace, and the demand for markers is further enhanced. Therefore, the sales of markers are likely to rise due to them becoming an integral part of a modern radiotherapy patient positioning system.
| End User | Radiation/Proton Therapy Centers |
|---|---|
| Value Share (2034) | 45.1% |
The radiation/proton therapy centers segment is forecast to account for a revenue of over USD 88.4 million in the Europe radiotherapy patient positioning market by 2034 end.
These centers play a central role in delivering essential care to patients that need radiotherapy interventions. They attract a high number of people needing medical assistance. They are thus, considered important in the provision of medical attention to various individuals seeking to be treated or assisted in other ways. They also increase dealer’s power within the market landscape because they provide accessibility and convenience.
Radiation and proton therapy centers are essential players in the healthcare system. This is because these centers plays a major role in efficient treatment of patients with cancer and other abnormalities requiring irradiation due to their highly knowledgeable medical personnel and use of advanced technology.
Additionally, their importance is enhanced by convenient walk-in booking and comprehensive patient-centeredness. Therefore, the fact that these institutes are becoming more and more well-known highlights how important they are to providing innovative radiation treatments and enhancing patient results throughout Europe.
The most important players in the radiotherapy patient positioning market are investing heavily in research and development as a means of driving innovation into such products as fiducial markers, vaginal markers or rectal marker. This is in addition to their focus on improving the effectiveness of products, seeking to make their product portfolios stronger through seeking partnership deals that are strategic and extending their presence in the European market.
Recent Industry Developments in Radiotherapy Patient Positioning Market
In terms of product, the industry is divided into thermoplastic masks & sheets (head masks, head & shoulder masks and torso & extremities), markers (fiducial markers, vaginal markers and rectal marker), immobilization system, head rest, cushions, spacers & wedges, arm & wrist support, locating & indexing bar and bite positioners
The industry is classified by end user as hospitals, cancer research institutes and radiation/proton therapy centres
Key countries such as Germany, Italy, France, UK, Spain, BENELUX, Russia and Rest of Europe have been covered in the report.
The Europe radiotherapy patient positioning industry is projected to witness CAGR of 3.8% between 2024 and 2034.
The Europe radiotherapy patient positioning industry stood at USD 130.1 million in 2023.
The Europe radiotherapy patient positioning industry is anticipated to reach USD 196.1 million by 2034 end.
Spain is set to record the highest CAGR of 3.6% in the assessment period.
The key players operating in the Europe radiotherapy patient positioning industry include Orfit Industries, Qfix, Elekta, Eckert & Ziegler BEBIG, CDR Systems, Roper Technologies-CIVCO, Best Medical Canada, Blessing Cathay Corporation, Candor ApS, IZI Medical Products, Klarity Medical Products, MacroMedics BV, OSL Oncology Systems Limited and pathesT-Tape Company B.V.
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Market Analysis 2019 to 2023 and Forecast 2024 to 2034
5.1. By Product
5.2. By End User
5.3. By Country
6. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product
6.1. Thermoplastic Masks & Sheets
6.1.1. Head Masks
6.1.2. Head & Shoulder Masks
6.1.3. Torso & Extremities
6.2. Markers
6.2.1. Fiducial Markers
6.2.2. Vaginal Markers
6.2.3. Rectal Marker
6.3. Immobilization System
6.4. Head Rest
6.5. Cushions
6.6. Spacers & Wedges
6.7. Arm & Wrist Support
6.8. Locating & Indexing Bar
6.9. Bite Positioners
7. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User
7.1. Hospitals
7.2. Cancer Research Institutes
7.3. Radiation/Proton Therapy Centres
8. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country
8.1. Germany
8.2. Italy
8.3. France
8.4. UK
8.5. Spain
8.6. BENELUX
8.7. Russia
8.8. Rest of Europe
9. Sales Forecast 2024 to 2034 by Product and End User for Europe Countries
10. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
11. Company Profile
11.1. Orfit Industries
11.2. Qfix
11.3. Elekta
11.4. Eckert & Ziegler BEBIG
11.5. CDR Systems
11.6. Roper Technologies-CIVCO
11.7. Best Medical Canada
11.8. Blessing Cathay Corporation
11.9. Candor ApS
11.10. IZI Medical Products
11.11. Klarity Medical Products
11.12. MacroMedics BV
11.13. OSL Oncology Systems Limited.
11.14. T-Tape Company B.V.
Explore Healthcare Insights
View Reports
Europe Radiotherapy Patient Positioning Market
